Race Oncology Ltd (rac) Logo

Race Oncology Ltd (RAC)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials

RAC ASX Chart

Snapshot

Race Oncology (ASX: RAC) is an ASX-listed clinical stage, a global biotechnology company with a dedicated mission to be at the heart of cancer care. Race's lead asset, bisantrene, is a small molecule anthracene chemotherapeutic. Bisantrene has a unique and rich clinical history with demonstrated therapeutic benefits in both adult and pediatric patients, a well characterised safety profile, and compelling clinical data demonstrating an anti-cancer effect and a lack of cardiotoxicity. 

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -25.51%
vs ASX 200 (1yr) -37.04%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 707 of 2,382
Sector Rank 48 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies ONE / PGC / CGS
EPS -$0.069
DPS $0.00
Book Value Per Share $0.135

Broker Consensus

RAC is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Sydney NSW 2000
Website www.raceoncology.com
Registry Automic Group
Auditor Hall Chadwick Audit (WA) Pty Ltd
Date Listed 13 Jul 2016

Upcoming Calendar (Forecasted)

Date Event
28/08/2024 Report (Prelim)
28/08/2024 Report (Annual)
23/10/2024 Report (Annual)
26/02/2025 Report (Interim)

Former Company Names

  • Race Oncology Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

RAC directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
04/12/23 Mary Harney Issued 1,170 $0.885 $1,035 Issue of options
04/12/23 Phillip(Phil) Lynch Issued 21,457 $0.885 $18,989 Issue of options
01/12/23 Mary Harney Issued 139,516 $0.850 $118,588 Issue of options
01/12/23 Peter (Pete) Smith Issued 440,019 $0.850 $374,016 Issue of options
03/03/23 Daniel Sharp Issued 110,392 $2.27 $250,589 Issue of options
03/03/23 Mary Harney Issued 110,392 $2.27 $250,589 Issue of options
03/03/23 Damian Clarke Bruce Issued 755,671 $2.27 $1,715,373 Issue of options
07/02/23 Daniel Tillett Buy +6,793 $1.92 $13,044 On-market trade
13/01/23 Daniel Tillett Buy +25,550 $1.97 $50,223 On-market trade
20/12/22 Daniel Tillett Buy +46,737 $2.12 $99,198 On-market trade
14/11/22 Daniel Tillett Buy +2,307,925 $0.206 $475,000 Exercise of options
14/11/22 Daniel Tillett Exercise 2,500,000 $0.190 $475,000 Exercise of options
03/11/22 Daniel Tillett Buy +4,826 $2.31 $11,152 On-market trade
05/10/22 Daniel Tillett Buy +23,914 $1.87 $44,823 On-market trade
23/09/22 Daniel Tillett Buy +83,954 $1.97 $165,441 On-market trade
16/05/22 Mary Harney Expiry 400 $1.89 $754 Options expired
16/05/22 Daniel Tillett Expiry 672,500 $1.88 $1,267,662 Options expired
16/05/22 Phillip(Phil) Lynch Expiry 20,958 $1.88 $39,505 Options expired
16/05/22 John Cullity Expiry 189,394 $1.88 $357,007 Options expired
04/03/22 Daniel Tillett Buy +20,301 $2.75 $55,763 On-market trade
10/01/22 John Cullity Sell +300,000 $3.32 ($995,174) On-market trade
21/12/21 Daniel Tillett Issued 10,000 $3.00 $30,000 Participation in share purchase plan
21/12/21 Mary Harney Issued 10,000 $3.00 $30,000 Participation in share purchase plan
21/12/21 Phillip(Phil) Lynch Issued 10,000 $3.00 $30,000 Participation in share purchase plan
14/12/21 Daniel Tillett Buy +2,271 $3.40 $7,732 On-market trade
10/12/21 Daniel Tillett Buy +17,729 $3.34 $59,188 On-market trade
12/11/21 John Cullity Buy +3,000,000 $0.237 $710,000 Exercise of options
12/11/21 John Cullity Exercise 3,000,000 $0.237 $710,000 Exercise of options
04/11/21 John Cullity Sell +217,878 $3.26 ($709,999) On-market trade
02/09/21 John Cullity Sell +61,745 $3.12 ($192,798) On-market trade
23/08/21 John Cullity Buy +1,893,939 $0.099 $187,499 Exercise of options
23/08/21 John Cullity Exercise 1,893,939 $0.099 $187,499 Exercise of options
28/06/21 Mary Harney Buy +5,400 $3.73 $20,118 On-market trade
19/05/21 Phillip(Phil) Lynch Issued 20,958 $3.20 $67,065 Issue of options
19/05/21 Daniel Tillett Issued 672,500 $3.20 $2,152,000 Issue of options
19/05/21 Mary Harney Issued 400 $3.20 $1,280 Issue of options
15/03/21 Mary Harney Buy +8,000 $3.95 $31,567 On-market trade
10/03/21 Daniel Tillett Buy +4,250,000 $0.099 $420,750 Exercise of options
10/03/21 Daniel Tillett Exercise 4,250,000 $0.099 $420,750 Exercise of options
30/11/20 Phillip(Phil) Lynch Issued 2,000,000 $2.08 $4,160,000 Issue of options
30/11/20 Daniel Tillett Issued 2,000,000 $2.08 $4,160,000 Issue of options
30/11/20 Borje Andersson Issued 118,577 $2.08 $246,640 Issue of securities
30/11/20 Borje Andersson Issued 1,600,000 $2.08 $3,328,000 Issue of options
25/06/20 Phillip(Phil) Lynch Buy +85,816 $0.460 $39,518 On-market trade
06/03/20 William (Bill) Garner Sell +4,000,000 $0.299 ($1,194,000) Off-market trade
28/02/20 Daniel Tillett Buy +45,000 $0.290 $13,063 On-market trade
28/02/20 Daniel Tillett Buy +45,000 $0.290 $13,063 On-market trade
04/12/19 Daniel Tillett Buy +155,000 $0.160 $24,825 On-market trade
26/11/19 Daniel Tillett Issued 2,500,000 $0.150 $375,000 Issue of securities
26/11/19 William (Bill) Garner Issued 1,000,000 $0.150 $150,000 Issue of options
26/11/19 Christopher Ntoumenopoulos Issued 1,000,000 $0.150 $150,000 Issue of options
26/11/19 John Cullity Issued 1,000,000 $0.150 $150,000 Issue of options
23/10/19 Daniel Tillett Buy +241,579 $0.125 $30,233 On-market trade
14/10/19 Christopher Ntoumenopoulos Expiry 2,000,000 $0.145 $290,000 Options expired
14/10/19 William (Bill) Garner Issued 757,575 $0.145 $109,848 Issue of options
14/10/19 John Cullity Issued 1,893,939 $0.145 $274,621 Issue of options
14/10/19 Christopher Ntoumenopoulos Issued 189,393 $0.145 $27,462 Issue of options
14/10/19 Christopher Ntoumenopoulos Issued 378,787 $0.066 $25,000 Issue of securities
14/10/19 John Cullity Issued 3,787,878 $0.066 $250,000 Issue of securities
14/10/19 William (Bill) Garner Issued 1,515,151 $0.066 $100,000 Issue of securities
06/08/19 William (Bill) Garner Transfer 5,000,000 $0.067 $335,000 Off-market transfer
06/08/19 William (Bill) Garner Transfer 5,000,000 $0.067 $335,000 Off-market transfer
12/07/19 William (Bill) Garner Buy +5,000,000 $0.050 $250,000 Conversion of securities
12/07/19 William (Bill) Garner Exercise 5,000,000 $0.050 $250,000 Conversion of securities
04/07/19 William (Bill) Garner Transfer 219,239 $0.050 $10,962 Off-market transfer
25/06/19 William (Bill) Garner Transfer 4,532,023 $0.065 $294,581 Off-market transfer
25/06/19 William (Bill) Garner Transfer 3,206,048 $0.065 $208,393 Off-market transfer
08/02/19 William (Bill) Garner Transfer 661,769 $0.085 $56,250 Off-market transfer
08/02/19 Christopher Ntoumenopoulos Transfer 53,847 $0.085 $4,577 Off-market transfer
08/02/19 William (Bill) Garner Transfer 107,696 $0.085 $9,154 Off-market transfer
08/02/19 William (Bill) Garner Transfer 21,600 $0.085 $1,836 Off-market transfer
02/01/19 William (Bill) Garner Transfer 50,000 $0.082 $4,100 Off-market transfer
24/12/18 William (Bill) Garner Transfer 712,406 $0.071 $50,581 Off-market transfer
21/12/18 William (Bill) Garner Transfer 9,951,301 $0.072 $716,494 Off-market transfer
21/12/18 William (Bill) Garner Exercise 5,000,000 $0.072 $360,000 Conversion of securities
21/12/18 William (Bill) Garner Transfer 7,958,879 $0.072 $573,039 Off-market transfer
21/12/18 William (Bill) Garner Buy +5,000,000 $0.072 $360,000 Conversion of securities
21/12/18 William (Bill) Garner Buy +5,000,000 $0.072 $360,000 Conversion of securities
20/12/18 Peter Molloy Transfer 113,593 $0.076 $8,633 Off-market transfer
07/12/18 William (Bill) Garner Transfer 1,071,708 $0.096 $102,884 Off-market transfer
27/11/18 John Cullity Issued 2,000,000 $0.125 $250,000 Issue of securities
09/11/18 William (Bill) Garner Sell +350,000 $0.135 ($47,263) On-market trade
09/11/18 William (Bill) Garner Transfer 1,360,775 $0.130 $176,901 Off-market transfer
12/09/18 William (Bill) Garner Transfer 955,782 $0.105 $100,357 Off-market transfer
28/08/18 William (Bill) Garner Buy +50,000 $0.144 $7,185 On-market trade
27/08/18 Peter Molloy Buy +45,000 $0.142 $6,374 On-market trade
15/06/18 Peter Molloy Buy +100,000 $0.241 $24,137 On-market trade
26/04/18 William (Bill) Garner Transfer 75,000 $0.300 $22,500 Off-market transfer
26/04/18 William (Bill) Garner Transfer 75,000 $0.300 $22,500 Off-market transfer
22/11/17 Christopher Ntoumenopoulos Issued 2,000,000 $0.350 $700,000 Issue of options
11/05/17 William (Bill) Garner Buy +75,000 $0.231 $17,312 On-market trade
30/03/17 Peter Molloy Buy +20,000 $0.211 $4,220 On-market trade
28/03/17 Christopher Ntoumenopoulos Buy +100,000 $0.201 $20,088 On-market trade
Show All

Director Interests

The current holdings of RAC directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Mary Harney 04/12/2023 0 23,400 251,078 N/A
Phillip(Phil) Lynch 04/12/2023 N/A 429,149 2,021,457 N/A
Peter (Pete) Smith 01/12/2023 0 N/A 440,019 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 25, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Dr Daniel Tillett 14,014,370 8.59%
Mr Phillip Richard Perry 6,047,694 3.71%
Mr Mark Phillip Juan 5,652,312 3.47%
Biosynergy Partners Pty Ltd 5,102,194 3.13%
The Trust Company (Australia) Limited <MOF A/C> 4,450,468 2.73%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 2,648,807 1.62%
Dr Daniel Tillett (ii) 2,307,925 1.42%
Craganorig Holdings LLC 2,000,000 1.23%
Marinella Messina 1,757,377 1.08%
Mr Phillip Richard Perry & Mrs Tetyana Perry <Doneska Super Fund A/C> 1,600,000 0.98%
Mr Anthony James Robinson <The Peeko Family No 86 A/C> 1,579,250 0.97%
Mr Kimberley Ross Gartrell & Mrs Jennifer Margaret Gartrell <K&J Gartrell Super Fund A/C> 1,350,000 0.83%
Kudoss Investments Pty Ltd <Aitken Global Family A/C> 1,153,034 0.71%
Mr Kenneth Barry Ridley & Mrs Catherine Mary Ridley <Ridley Retirement Fund A/C> 1,080,000 0.66%
Mr Sandor Helby 1,060,000 0.65%
Mr Alan Giles Sauran 1,031,256 0.63%
Biosynergy Partners Pty Ltd (ii) 1,000,000 0.61%
Citicorp Nominees Pty Limited 856,443 0.53%
Mr Van Quy Do 825,788 0.51%
Mr Brian James Walker 777,777 0.48%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 3,552 2,494 805 1,426 247 8,524

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Daniel Tillett 25/08/2023 16,322,295 10.01

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
12-05-23 John Cullity 8,402,194 5.62 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $1.23 30 June
2022 $1.95 30 June
2021 $3.67 30 June
2020 $0.700 30 June
2019 $0.053 28 June
2018 $0.210 29 June
2017 $0.225 28 June
RAC Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.